{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:59:35Z","timestamp":1790261975410,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31271022"],"award-info":[{"award-number":["31271022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology","award":["2014ZX09303301"],"award-info":[{"award-number":["2014ZX09303301"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.actbio.2016.04.014","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T10:06:34Z","timestamp":1460282794000},"page":"143-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-\u03b5-caprolactone (PCL)"],"prefix":"10.1016","volume":"37","author":[{"given":"Shumao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bifei","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2016.04.014_b0005","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/bjo.2009.178574","article-title":"Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review","volume":"95","author":"Schmucker","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.actbio.2016.04.014_b0010","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ophtha.2009.01.039","article-title":"Triamcinolone acetonide concentration of aqueous humor after decanted 20-mg intravitreal injection","volume":"116","author":"Cheng","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2016.04.014_b0015","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ajo.2004.05.028","article-title":"Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection","volume":"138","author":"Inoue","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.actbio.2016.04.014_b0020","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archophthalmol.2009.234","volume":"127","author":"Ip","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.actbio.2016.04.014_b0025","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/jop.2012.0180","article-title":"A comparison between the fluocinolone acetonide (retisert) and dexamethasone (ozurdex) intravitreal implants in uveitis","volume":"29","author":"Arcinue","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.actbio.2016.04.014_b0030","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10792-012-9604-7","article-title":"Repositioning of dexamethasone intravitreal implant (Ozurdex\u00ae) migrated into the anterior chamber","volume":"32","author":"Vela","year":"2012","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.actbio.2016.04.014_b0035","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00417-011-1802-x","article-title":"Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex(R))","volume":"250","author":"Pardo-Lopez","year":"2012","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.actbio.2016.04.014_b0040","doi-asserted-by":"crossref","DOI":"10.1007\/s40123-015-0035-1","article-title":"A novel technique for repositioning of a migrated ILUVIEN(Fluocinolone Acetonide) implant into the anterior chamber","author":"El-Ghrably","year":"2015","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.actbio.2016.04.014_b0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1076\/opep.5.3.143.8364","article-title":"The global impact of eye injuries","volume":"5","author":"Negrel","year":"1998","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.actbio.2016.04.014_b0050","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0161-6420(97)30167-5","article-title":"Post traumatic proliferative vitreoretinopathy \u2013 the epidemiologic profile, onset, risk factors, and visual outcome","volume":"104","author":"Cardillo","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2016.04.014_b0055","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/bjo.79.10.874","article-title":"Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal diseases","volume":"79","author":"Mietz","year":"1995","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.actbio.2016.04.014_b0060","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(02)01969-3","article-title":"Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection","volume":"110","author":"Beer","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2016.04.014_b0065","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/bjo.2009.172106","article-title":"Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-Tenon injection","volume":"94","author":"Nan","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.actbio.2016.04.014_b0070","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.ophtha.2010.03.033","article-title":"Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application","volume":"117","author":"Shen","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2016.04.014_b0075","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/IAE.0b013e318163194c","article-title":"ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema","volume":"28","author":"Kim","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.actbio.2016.04.014_b0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0168-3659(02)00207-9","article-title":"Design of poly-\u03b5-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery","volume":"83","author":"Barbault-Foucher","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2016.04.014_b0085","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.nano.2009.02.003","article-title":"Nanomedicines for ocular NSAIDs: safety on drug delivery","volume":"5","author":"Ara\u00fajo","year":"2009","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.actbio.2016.04.014_b0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.actbio.2013.09.022","article-title":"Sustained release of triamcinolone acetonide from an episcleral plaque of multilayered poly-epsilon-caprolactone matrix","volume":"10","author":"Meng","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2016.04.014_b0095","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1167\/iovs.12-11460","article-title":"Different intravitreal properties of three triamcinolone formulations and their possible impact on retina practice","volume":"54","author":"Chen","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.actbio.2016.04.014_b0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000063123","article-title":"Dimensional growth of the rabbit eye","volume":"171","author":"Barathi","year":"2002","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.actbio.2016.04.014_b0105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9394(99)80096-8","article-title":"Human sclera: thickness and surface area","volume":"125","author":"Olsen","year":"1998","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.actbio.2016.04.014_b0110","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1167\/iovs.08-2410","article-title":"Steroid-induced ocular hypertension in normal sheep","volume":"50","author":"Gerometta","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.actbio.2016.04.014_b0115","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1001\/archopht.122.10.1492","article-title":"Steroid-induced ocular hypertension in normal cattle","volume":"122","author":"Gerometta","year":"2004","journal-title":"Arch. Ophthalmol. Chic"},{"key":"10.1016\/j.actbio.2016.04.014_b0120","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1089\/jop.2013.0061","article-title":"Meta-analysis of the effect of intravitreal bevacizumab versus intravitreal triamcinolone acetonide in central retinal vein occlusion","volume":"29","author":"Jin","year":"2013","journal-title":"J. Ocul. Pharmacol Ther."},{"key":"10.1016\/j.actbio.2016.04.014_b0125","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1097\/IAE.0b013e31824fd384","article-title":"Comparison of intraocular pressure elevation after anterior versus posterior subtenon triamcinolone acetonide acetate injection: a retrospective study","volume":"32","author":"Liu","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.actbio.2016.04.014_b0130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archopht.121.5.667","article-title":"A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results","volume":"121","author":"Gillies","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.actbio.2016.04.014_b0135","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ophtha.2007.02.010","article-title":"Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema \u2013 A pilot study","volume":"114","author":"Chew","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2016.04.014_b0140","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/IAE.0b013e3181f049a8","article-title":"Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema","volume":"31","author":"Chew","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.actbio.2016.04.014_b0145","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/IJG.0b013e31802d696f","article-title":"Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection","volume":"16","author":"Iwao","year":"2007","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.actbio.2016.04.014_b0150","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.ophtha.2010.03.033","article-title":"Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40mg posterior subtenon application","volume":"117","author":"Shen","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2016.04.014_b0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpharm.2006.05.053","article-title":"Biodegradable scleral implants as new triamcinolone acetonide delivery systems","volume":"322","author":"Felt-Baeyens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2016.04.014_b0160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejpb.2008.04.023","article-title":"A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide","volume":"70","author":"Kim","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2016.04.014_b0165","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1167\/iovs.08-1989","article-title":"Pharmacokinetics of intraocular drug delivery of oregon green 488\u2013labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes","volume":"49","author":"Lee","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.actbio.2016.04.014_b0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/jop.2008.0086","article-title":"Biodegradable intrascleral implant of triamcinolone acetonide in experimental uveitis","volume":"25","author":"Shin","year":"2009","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.actbio.2016.04.014_b0175","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1113\/jphysiol.1956.sp005537","article-title":"A comparative study of the total carbon dioxide in the ocular fluids, cerebrospinal fluid, and plasma of some mammalian species","volume":"132","author":"Davson","year":"1956","journal-title":"J. Physiol. London"},{"key":"10.1016\/j.actbio.2016.04.014_b0180","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.visres.2006.12.019","article-title":"Emmetropization and schematic eye models in developing pigmented guinea pigs","volume":"47","author":"Howlett","year":"2007","journal-title":"Vis. Res."},{"key":"10.1016\/j.actbio.2016.04.014_b0185","first-page":"551","article-title":"Scleral thickness topography of the adult Chinchilla pigmented rabbit with implications for transscleral drug delivery research","volume":"15","author":"Li","year":"2013","journal-title":"Chin. J. Optom. Ophthalmol. Vis. Sci."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706116301672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706116301672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T07:10:57Z","timestamp":1572765057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706116301672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":37,"alternative-id":["S1742706116301672"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2016.04.014","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-\u03b5-caprolactone (PCL)","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2016.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}